Lingwei Wang

2.3k citations
65 papers · 1.8k indexed · h-index 22

Lingwei Wang

62 papers receiving 1.7k citations

Peers

Lingwei Wang
Comparison fields: 5 of 131
  • Physiology 554
  • Internal Medicine 88
  • Cardiology and Cardiovascular Medicine 456
  • Endocrine and Autonomic Systems 120
  • Hematology 172
Replace Marek Radomski with:
Marek Radomski Canada
B. A. J. Evans United Kingdom
Kang Sun China
Yali Zhou China
Paul Jurasz Canada
Ying Yu China
Zhenguo Liu United States
Yang Yu China
Mohamed A. Zayed United States
Lei Cao China
Lingwei Wang relative to Marek Radomski Canada Marek Radomski's profile →
Citations per field
00.5×10×20×34.6×
Marek Radomski · 1×
Citations per year

Countries citing papers authored by Lingwei Wang

Since Specialization
Citations

This map shows the geographic impact of Lingwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingwei Wang more than expected).

Fields of papers citing papers by Lingwei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingwei Wang. The network helps show where Lingwei Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lingwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lingwei Wang Line = papers co-authored together Lingwei Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20241
4 20243
5 20236
6 20232
7 20234
8 20220
9 20223
10 202251
11 20212
12 20213
13 20202
14 202020
15 202028
16 20197
17 20117
18 20057
19 200423
20 2002182

About Lingwei Wang

Lingwei Wang is a scholar working on Physiology, Microbiology and Cardiology and Cardiovascular Medicine, having authored 65 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cardiac pacing and defibrillation studies (16 papers), Cardiac Arrhythmias and Treatments (16 papers), Cardiac electrophysiology and arrhythmias (10 papers), Adenosine and Purinergic Signaling (7 papers), Nitric Oxide and Endothelin Effects (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Asthma and respiratory diseases (3 papers). The work is most often cited by research in Physiology (554 citations), Internal Medicine (88 citations) and Cardiology and Cardiovascular Medicine (456 citations). Lingwei Wang has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include David Erlinge, Sverker Jern, Lena Karlsson, Anders Bengtsson, Tómas Guðbjartsson, Sten Eirik W. Jacobsen, Helén Brogren, Catharina Borna, Maria Andersson and Maria Andersson. Their work appears in journals such as Annals of Translational Medicine, Pacing and Clinical Electrophysiology, Scandinavian Cardiovascular Journal, Circulation Research and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026